Md. biotech to be acquired by New Jersey pharmaceutical goliath

The final price, a bit more than a billion dollars, includes upfront cash and payments based on achieving certain milestones.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.